View Full Version : Clinical Trials
- FDA Scraps Helsinki Declaration on Protecting Human Subjects (4 replies)
- Bavituximab Phase II Breast Cancer Trial (0 replies)
- Phase II lapatinib trial results for HER2's w/brain mets (0 replies)
- Radioembolization promising for inoperable chemorefractory liver metastases (1 replies)
- Phase III Study of IMC-1121B (0 replies)
- Rads fatigue trial (0 replies)
- Illinois trial /cancer cytokines & activity (2 replies)
- Newly diagnosed postmeno flaxseed and/or anastrozole trial (0 replies)
- Omega-3 fatty acids, DCIS/ADH trial (1 replies)
- Starting a new clinical trial (21 replies)
- Do anybody know about this ??? (2 replies)
- Anti-cancer smart bomb ready for human use (0 replies)
- More on the ALTTO Trial (0 replies)
- Herceptin / Tykerb Trials (0 replies)
- Started Omnitarg(placebo)Taxotere, Herceptin trial (1 replies)
- Bnc105 (3 replies)
- Crossing My Fingers On Mcc- Dm1 Study (31 replies)
- New Generation of Clinical Trials Could Improve Patient Care (2 replies)
- natural aromatase inhibitors? (1 replies)
- Trastuzumab-MCC-DM1 trial (23 replies)
- Pertuzumab (Omnitarg™) and Herceptin® (Trastuzumab) (4 replies)
- Any one heard of this trial ESAI E3789 (1 replies)
- Trastuzumab-dm1 (5 replies)
- Angiogenesis in Early Breast Cancer for Prognosis Prediction (0 replies)
- targeting the hSSB1 gene without harming healthy cells (1 replies)
- Breast Sensation after postmastectomy breast reconstruction (2 replies)
- MDAnderson Her2+ FEC... (0 replies)
- Positive news and phase II trial from Roche (0 replies)
- Her2 and Inflammatory BC trial (0 replies)
- Is anybody participating in this Her2 vaccine clinical trial? (0 replies)
- KX2-391, protein kinase inhibitor (0 replies)
- Soy trial in Great Britain for bc risk (includes CHOCOLATE!!!) (1 replies)
- Phase II trial of bavituximab with docetaxel to start in '08 (1 replies)
- Nurses' bc study (0 replies)
- Recommended trial at Sloan (2 replies)
- Trial Trastuzumab-MCC-DM1(One more on this trial) (89 replies)
- Lapatinib for DCIS Trial (0 replies)
- new and improved angiogenesis treatment (anti-PLGF) (0 replies)
- Nanoparticle paclitaxel (Nanoxel) (0 replies)
- Photodynamic Therapy Shrinks Tumors (0 replies)
- Examining neurocognitive changes in patients receiving adjuvant therapy for bc (0 replies)
- Radioactive Spheres Effectively Treat Cancer That Has Spread To The Liver (1 replies)
- Scientists one step closer to cancer vaccine (0 replies)
- Addition of Xeloda® to Herceptin® and Taxotere® Delays Cancer Progression in Advanced (2 replies)
- Paclitaxel & trastuzumab for node neg HER2 pos (0 replies)
- RTA 744 in Breast Cancer Patients With Progression of Previously Irradiated Brain Met (0 replies)
- Flower Power: A Cure for Cancer? (0 replies)
- DCA trials approved for Alberta (0 replies)
- Can anyone help? (7 replies)
- Trial Trastuzumab-MCC-DM1 (I think it's working) (64 replies)
- Cancer cure 'may be available in two years' (2 replies)
- Alvespimycin Benefits Patients with Heavily Pretreated HER2-positive Cancer (0 replies)
- A New Formulation of Herceptin (0 replies)
- Vaccine sounds exciting...bring it on!! (2 replies)
- AIDS drug trialed against solid tumours in Bethesda (0 replies)
- GSK Tykerb Adjuvant Therapy Info (0 replies)
- Stanford/SF Bay study for circadian rhythm/hormones for those with mets (3 replies)
- Green tea study for ER-/PR- NEDs (0 replies)
- Clinical trials and medical insurance coverage (1 replies)
- Phase I Clinical Trial for GSK-923295 (0 replies)
- Herceptin DM-2 Phase II Trial (1 replies)
- Interesting Trial -- Drug Crosses Blood Brain Barrier (0 replies)
- Preventing early stage bc weight gain while doing chemo (Fox Chase) (0 replies)
- Israeli trial - "Angry' Cell Treatment (2 replies)
- Tykerb/xeloda Scan Update (6 replies)
- New Clinical Trials including brain mets (1 replies)
- Ixabepilone Clearly Active in Breast Cancer Resistant to Other Treatments (0 replies)
- Zactima Metronomic Therapy Trial for Mets, at Dana Farber (1 replies)
- Trial for validation of circulating tumor cells in newly diagnosed mets (0 replies)
- Phase II Bisphonates Trial-Should I participate? (6 replies)
- Golden bullet cancer killer (2 replies)
- Phase I Trial Of VB6-845 Anti-Cancer Antibody (0 replies)
- Broad Efficacy Of Azixa Against Drug Resistant Tumors (0 replies)
- Panzem NCD and Taxol (0 replies)
- New Vaccine Trial (0 replies)
- Vinflunine + Herceptin Interesting Prelim Data (0 replies)
- Phase III Ixabepilone Study Demonstrated Significant Improvement (0 replies)
- Positive Results In Bavituximab Combination Therapy Trial (0 replies)
- Anyone on Herceptin & Tacotere & Avastin (0 replies)
- Trial for finding better markers (0 replies)
- Vaccine for those with mets (4 replies)
- An Aussie trial (0 replies)
- To share with those who haven't had bc... yet (0 replies)
- Erbitux+Irinotecan+Carboplatin (0 replies)
- Hyperbaric O2 trial for jaw osteonecrosis from bisphosphonates (0 replies)
- Neoadjuvant ER &/or PR positive stage II-III Femara/Avastin phase II study (1 replies)
- Brain Metastis - WHole Brain RT (2 replies)
- Brain Metastis - WHole Brain RT (0 replies)
- Just Checkin In (0 replies)
- Neoadjuvant Phase II HER2 study for Stage III or IV (3 replies)
- Phase Ii Clinical Trials For Cyc202 (0 replies)
- Two Phase I/II Clinical Trials with Nab-Docetaxel (0 replies)
- Study to Assess Value of Routine Brain Metastases Screening in Patients with Advanced (0 replies)
- PI3K Inhibitor SF1126 (0 replies)
- For those on the wee lands across the pond (0 replies)
- Tykerb xeloda stopped working (7 replies)
- Free Brain Met Study - Chicago Area (0 replies)
- Low-carb diet / PET scans, for those with mets (0 replies)
- Off Omnitarg/Herceptin Trial...darn! (3 replies)
- more questions about anemia drugs (8 replies)
- MINDACT phase III for newly diagnosed node-negatives (0 replies)
- Phase II Trial: TACE/chemoembolisation for liver mets (0 replies)
- Phase II Vaccine Trials (2 replies)
- Late adjuvant Herceptin trial for NED HER2's (2 replies)
- Eligibility to US clinical trials (4 replies)
- Assessment Imaging Trial (2 replies)
- Aussie trial for detecting bc (1 replies)
- BN ImmunoTherapeutics Starts Trials with New Breast Cancer Vaccine (1 replies)
- Gemcitabine and Oxaliplatin - Greece (0 replies)
- Bavarian Nordic arm to start cancer vaccine trials (0 replies)
- Any info on HKI-272? (9 replies)
- info about cancers ? (0 replies)
- ARRY-520: KSP inhibitor (1 replies)
- Novel Orally-Active Kinase Inhibitor Induces Tumor Regression (0 replies)
- Genetically Modified Cells Attack Tumors (0 replies)
- ***Glaxo starts test of Tykerb in early breast cancer*** (10 replies)
- velcade(already FDA approved) and Herceptin synergistic --trial starting (1 replies)
- Looking for Lapatinib (4 replies)
- Johns Hopkins vaccine study for stage IV (0 replies)
- Michigan study, bone density (0 replies)
- clinical trial to see if acupuncture helps chemotherapy symptoms, tolerability (0 replies)
- Jean and others--new trial opening to determine whether arimidex/femara moreeffective (0 replies)
- MVA-BN®-based vaccine (1 replies)
- KOS-1022 Kosan HSP90 inhibitor trial? (0 replies)
- TroVax or HER2 neu trial more effective for HER2neu? (6 replies)
- AVEO Pharmaceuticals Initiates Clinical Development of AV-412 in Cancer Patients... (0 replies)
- tykerb studies for nonmetastatic bc? (4 replies)
- new drug: vinflunine (0 replies)
- Lapatinib/Xeloda dosing (1 replies)
- oral vinorelbine+Herceptin clinical trial results (0 replies)
- more from Istanbul--Breast cancer group award and start of new trial (1 replies)
- I'm from Canada..hoping to get into Omnitarg/Herceptin Trial. (0 replies)
- Preventing heart damage (0 replies)
- Trial for Stress Mgmt for those receiving chemo (0 replies)
- strategies for delaying or treating acquired resistance to Herceptin outlined!! (0 replies)
- Clinical Trial - Herceptin use in Stage I BC - Post Menopausal Women (0 replies)
- JOe Please help : Need to find sites in The Nethelands for Tykerb EAP (1 replies)
- for those w multiple brain mets--report of Phase I evaluation of new drug combination (1 replies)
- kat in the Delta (0 replies)
- Anyone Else Forced to Stop Herceptin? (7 replies)
- EAP - Tykerb, The list is growing (0 replies)
- Lapatinib EAP (4 replies)
- Study to determine if genotype determines response to AI's (0 replies)
- New vaccine trial starting (4 replies)
- Back Home from Seattle (9 replies)
- Life Insurance, purchasing additional amounts, after 4 times... (1 replies)
- New Phase II Trial of Combined Monoclonal Antibodies (2 replies)
- Trial for stage IV - molecular detection of breast cancer cells (0 replies)
- Trial for the HER2+ or HER2++ with advanced bc or mets (0 replies)
- Her 2 Protein Auto Vac? (4 replies)
- More evidence breast implants pose no cancer risk (3 replies)
- Trial for high-risk NEDs (0 replies)
- Exercise trial (0 replies)
- Michele and other Stage IIIb, IIIc and IV patients... (0 replies)
- Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/neu-... (0 replies)
- Bevacizumab and Trastuzumab (Herceptin®) in Treating Women With Relapsed or... (0 replies)
- Vaccine Therapy With Either Neoadjuvant or Adjuvant Chemotherapy and Adjuvant... (0 replies)
- Vaccine Therapy With Either Neoadjuvant or Adjuvant Chemotherapy and Adjuvant Radiati (0 replies)
- Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II... (0 replies)
- Phase I-II Study of Trastuzumab in Combination With RAD001 in Patients With HER-2... (3 replies)
- Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer... (0 replies)
- PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast Cancer (0 replies)
- Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB (0 replies)
- ErbB2 Over-Expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab... (0 replies)
- Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects Wi (1 replies)
- New vaccine - patients stage III or in remission (2 replies)
- Her-2 Vaccine Papers (3 replies)
- denosumab - exciting option for bone mets (0 replies)
- Clinical trial for Pre menopausal Women who are ER+, PR+ to compare tamoxifen with ov (7 replies)
- Personalized Treatment Trial....TAILORx (1 replies)
- Clinical Trial for PTEN-deficient Mets progressing on trastuzumab-based therapy (3 replies)
- Successful tests boost hope for cancer vaccine (1 replies)
- kat in the Delta (2 replies)
- U of WA Protocol 109 (13 replies)
- Herceptin now being tried intrathecally (injected into the brain via the CSF) (1 replies)
- Phase II Trial of Letrozole plus Tarceva (0 replies)
- Clinical trial of trifunctional antibody in hormonally positive her2 patients (0 replies)
- 17-AAG at Sloan Kettering (0 replies)
- My first UW vaccine trial (17 replies)
- BT blood test that may be more accurate than mammos (1 replies)
- Tesmilifene wins fast track review (1 replies)
- In hospital psych counseling effects on immunity (1 replies)
- GSK Announces Worldwide Trials for Brain Mets (0 replies)
- HER2's with mets trial (2 replies)
- Vaccine trial and positive ANA (2 replies)
- Xanafide (0 replies)
- Walter Reed/Windber Medical Center Interim Vaccine Results (0 replies)
- audio from SABCS (0 replies)
- What will they think of next?? (0 replies)
- A Long List Of Trials - Clinical Trials.gov (0 replies)
- PHASE II CLINICAL TRIAL OF KOS-953 & HERCEPTIN® FOR Stage IV (0 replies)
- Herceptin, post chemo or not? (23 replies)
- Lapatinib-we need your help. (3 replies)
- Clinical Trial for Pre-Menopausal Women w/ BC (0 replies)
- European Vaccine Trial (1 replies)
- Provecta/PV10 in recurrent BC (0 replies)
- Tarceva (0 replies)
- Cancer Vaccines: Decades of failure haven't extinguished hope for Vaccines (0 replies)
- HLA-positive testing? (2 replies)
- To Lolly and Others on the Uof W vaccine (2 replies)
- To Lolly and Others on the UofW Vaccine (0 replies)
- LAPATINIB - an update... (3 replies)
- Clinical trials w/ immunotherapy for BC (0 replies)
- Abraxane/Carbo/Herceptin Trial Anyone? (2 replies)
- E75 Vaccine (7 replies)
- KimDC, Susanne anyone else planning on E75 vaccine (10 replies)
- Herceptin 2 years out from chemo (5 replies)
- provecta trial (0 replies)
- Sonus starts key trial for breast cancer drug (0 replies)
- Is this onc for real? Herceptin weekly/everythree weeks trials (27 replies)
- Out of GW572016 Trial anyone know of anyting new? (6 replies)
- exciting new vaccine trial on the way (3 replies)
- EGFR expression increased in ER+/PR- bc (1 replies)
- "Girls Club Meeting" in Seattle (0 replies)
- I am in the herceptin/avastin trial (5 replies)
- Improving The Potential Of Cancer Vaccines (1 replies)
- Phase 1 trial of first biologic nanoparticle (0 replies)
- Exelexis XL647 to enter phase II trial (0 replies)
- Pharmexa Her2 Protein Autovac (0 replies)
- Anyone else in Herceptin+Avastin trial? (4 replies)
- Vaccine Trial/Immune Response Update (0 replies)
- PV-10 (2 replies)
- A Touch of Hope for Vaccine Recipients (14 replies)
- Help!, Need A2 alelle information (0 replies)
- UW Seattle/Vaccine (9 replies)
- tarceva erlotinib (0 replies)
- peripheral nerve sheath sarcoma (2 replies)
- Side Effects (6 replies)
- Not Eligible for UofW vaccine studies (1 replies)
- Clinical Trial- Tumor Vaccine Group, Seattle (4 replies)
- Herceptin Trial (11 replies)
- OOOOPS! (1 replies)
- UW Vaccine Immune Response/Update (2 replies)
- UW Vaccine Immune Response/Update (0 replies)
- UW Vaccine Immune Response/Update (0 replies)
- UW Vaccine Immune Response/Update (0 replies)
- UW Vaccine Immune Response/Update (0 replies)
- UW Vaccine Immune Response/Update (0 replies)
- UW Vaccine Immune Response/Update (3 replies)
- UW Vaccine Immune Response/Update (0 replies)
- How often to get heart scans when using herceptin (10 replies)
- clinical trial for inflamatory BC (0 replies)
- Avastin and Herceptin (4 replies)
- ER Negative / Her2 Positive (0 replies)
- Upcoming UW Trial Includes Brain Mets People (2 replies)
- UW Seattle Vaccine Trial (6 replies)
- herceptin (3 replies)
- another vaccine trial (0 replies)
- new vaccine trial (0 replies)
- investigational drug CCI-779 and letrozole, New Cl (0 replies)
vBulletin® v3.8.7, Copyright ©2000-2026, vBulletin Solutions, Inc.